ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

Professional Societies: AACR Awards Honor 8 Scientists, Clinicians

April 2, 1999

Surgery Lowers Risk By 90% In Women With Gene Mutations

April 30, 2004

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

Cooperative Group Chairman Objects “Personal” Comments, Other Deficiencies In Peer Review

January 16, 1981

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

November 14, 1986